Cervical Cancer and HPV Research

Cervical cancer is caused almost entirely by persistent infection with certain strains of Human Papillomavirus, making it one of the few cancers with a well-defined infectious origin and, in principle, a preventable one. Epidemiologists in this area track how HPV genotypes vary across populations, how vaccination programs are reshaping cancer incidence over time, and where cytology-based screening succeeds or falls short in detecting precancerous changes before they progress. Despite the availability of effective vaccines, cervical cancer remains a leading cause of cancer death in low- and middle-income countries, largely because of uneven access to both immunization and screening infrastructure. Active research questions include how viral oncoproteins drive malignant transformation at the molecular level, which genotypes carry the greatest carcinogenic risk beyond the well-characterized HPV 16 and 18, and how surveillance systems can better quantify the true global burden of HPV-related disease.

Works

153,282

Total citations

2,028,367

Keywords

Human PapillomavirusCervical CancerHPV VaccinationEpidemiologyCancer IncidenceCytology Screening